Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank50
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-8.42
↑ 13% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthNormalizing
Average
-9.67
Historical baseline
PeriodValueYoY Change
2025-8.42+29.3%
2024-11.90-73.1%
2023-6.87-153.2%
2022-2.71+4.5%
2021-2.84+86.1%
2020-20.42-84.8%
2019-11.05+51.7%
2018-22.86-
20170.00-